Pfizer signs deal with Gilead to manufacture COVID19 antiviral remdesivir — Biogen gets speedy FDA review for Alzheimer's med — Roche Tecentriq--chemo combo fails in triple negative breast cancer — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
Dismiss Notice
Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
Dismiss Notice

LabSource

Anonymous board for LabSource